Stanford Hospital and Clinics, Investigational Drug Services — Stanford, California

Stanford Hospital and Clinics, Investigational Drug Services is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford Hospital and Clinics, Investigational Drug Services has participated in 1 clinical trials.

Therapeutic areas: Peripheral T-cell Lymphoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Hospital and Clinics, Investigational Drug Services?

Stanford Hospital and Clinics, Investigational Drug Services has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Hospital and Clinics, Investigational Drug Services conducted?

Stanford Hospital and Clinics, Investigational Drug Services has 1 clinical trials on record. Their work covers Peripheral T-cell Lymphoma.

Is Stanford Hospital and Clinics, Investigational Drug Services accredited by Crixeo Health?

Stanford Hospital and Clinics, Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Hospital and Clinics, Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.